Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Cash & Current Investments (2019 - 2025)

Historic Cash & Current Investments for IM Cannabis (IMCC) over the last 7 years, with Q3 2025 value amounting to $1.7 million.

  • IM Cannabis' Cash & Current Investments rose 1721.92% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 1721.92%. This contributed to the annual value of $677080.3 for FY2024, which is 4961.2% down from last year.
  • Latest data reveals that IM Cannabis reported Cash & Current Investments of $1.7 million as of Q3 2025, which was up 1721.92% from $651706.4 recorded in Q2 2025.
  • In the past 5 years, IM Cannabis' Cash & Current Investments registered a high of $27.7 million during Q2 2021, and its lowest value of $646041.6 during Q1 2025.
  • In the last 5 years, IM Cannabis' Cash & Current Investments had a median value of $1.8 million in 2023 and averaged $5.7 million.
  • Per our database at Business Quant, IM Cannabis' Cash & Current Investments soared by 6200.15% in 2021 and then plummeted by 8365.9% in 2022.
  • Quarter analysis of 5 years shows IM Cannabis' Cash & Current Investments stood at $11.0 million in 2021, then plummeted by 83.66% to $1.8 million in 2022, then decreased by 26.19% to $1.3 million in 2023, then tumbled by 50.17% to $663592.2 in 2024, then surged by 153.54% to $1.7 million in 2025.
  • Its Cash & Current Investments stands at $1.7 million for Q3 2025, versus $651706.4 for Q2 2025 and $646041.6 for Q1 2025.